BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 16721394)

  • 1. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
    Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
    Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults.
    Christensen HR; Larsen CN; Kaestel P; Rosholm LB; Sternberg C; Michaelsen KF; Frøkiaer H
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):380-90. PubMed ID: 16872374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
    Klein A; Friedrich U; Vogelsang H; Jahreis G
    Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
    Ahmed M; Prasad J; Gill H; Stevenson L; Gopal P
    J Nutr Health Aging; 2007; 11(1):26-31. PubMed ID: 17315077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention.
    Roessler A; Friedrich U; Vogelsang H; Bauer A; Kaatz M; Hipler UC; Schmidt I; Jahreis G
    Clin Exp Allergy; 2008 Jan; 38(1):93-102. PubMed ID: 18028460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
    Rizzardini G; Eskesen D; Calder PC; Capetti A; Jespersen L; Clerici M
    Br J Nutr; 2012 Mar; 107(6):876-84. PubMed ID: 21899798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
    Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
    Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.
    de Vrese M; Winkler P; Rautenberg P; Harder T; Noah C; Laue C; Ott S; Hampe J; Schreiber S; Heller K; Schrezenmeir J
    Clin Nutr; 2005 Aug; 24(4):481-91. PubMed ID: 16054520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults.
    Olivares M; Díaz-Ropero MA; Gómez N; Lara-Villoslada F; Sierra S; Maldonado JA; Martín R; López-Huertas E; Rodríguez JM; Xaus J
    Int J Food Microbiol; 2006 Mar; 107(2):104-11. PubMed ID: 16271414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
    Saarela M; Maukonen J; von Wright A; Vilpponen-Salmela T; Patterson AJ; Scott KP; Hämynen H; Mättö J
    Int J Antimicrob Agents; 2007 Mar; 29(3):271-80. PubMed ID: 17207972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial.
    Vlieger AM; Robroch A; van Buuren S; Kiers J; Rijkers G; Benninga MA; te Biesebeke R
    Br J Nutr; 2009 Sep; 102(6):869-75. PubMed ID: 19331702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.
    Roessler A; Forssten SD; Glei M; Ouwehand AC; Jahreis G
    Clin Nutr; 2012 Feb; 31(1):22-9. PubMed ID: 21963389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.
    Merenstein DJ; Tan TP; Molokin A; Smith KH; Roberts RF; Shara NM; Mete M; Sanders ME; Solano-Aguilar G
    Gut Microbes; 2015; 6(1):66-77. PubMed ID: 25569274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Eskesen D; Jespersen L; Michelsen B; Whorwell PJ; Müller-Lissner S; Morberg CM
    Br J Nutr; 2015 Nov; 114(10):1638-46. PubMed ID: 26382580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans.
    Bouhnik Y; Attar A; Joly FA; Riottot M; Dyard F; Flourié B
    Eur J Clin Nutr; 2004 Mar; 58(3):462-6. PubMed ID: 14985684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.
    Bartosch S; Woodmansey EJ; Paterson JC; McMurdo ME; Macfarlane GT
    Clin Infect Dis; 2005 Jan; 40(1):28-37. PubMed ID: 15614689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of fecal microbiota in hospitalized elderly fed probiotic LKM512 yogurt.
    Matsumoto M; Sakamoto M; Benno Y
    Microbiol Immunol; 2009 Aug; 53(8):421-32. PubMed ID: 19659926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.
    Taipale T; Pienihäkkinen K; Isolauri E; Larsen C; Brockmann E; Alanen P; Jokela J; Söderling E
    Br J Nutr; 2011 Feb; 105(3):409-16. PubMed ID: 20863419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
    Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
    J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.